Start date: 30 Jun 2010
End date: 03 Jul 2010
Location: Barcelona, Spain

ESMO’s 12th World Congress on Gastrointestinal Cancer was an unquestionable success and beneficial for all who participated!

Record attendance, with more than 3,400 attendees from 95 countries
Extensive coverage in the international press
Endorsement from major societies and organisations

The scientific agenda of the 2010 Congress made it the most comprehensive and most effective in addressing the educational needs of physicians.

72 international expert specialists led high quality sessions on a wide array of topics and met with participants in small, targeted groups
Special sessions for young medical oncologists and nurses, plus 7 satellite symposia, provided targeted educational opportunities

Presentation of cutting-edge research is one of the highlights of the World Congress. More than 400 abstracts were presented in the expansive poster sessions and published in a special supplement to the Annals of Oncology, representing the latest research from across the globe in colon, oesophageal, gastric, liver, pancreatic and rectal cancer. 16 travel grants were awarded to abstract submitters from developing nations.
Abstracts this year featured:

Significant new data on neuroendocrine tumours
New Phase 3 studies
Updated information on new treatment in colorectal cancer
Updates on molecular profiling of colon cancer
Updates on new targeted agents in gastric cancer
Updates on large trials on colorectal cancer